What is the best course of action for a 22-year-old female with lower abdominal pain, elevated liver enzymes (aspartate aminotransferase (AST) and alanine aminotransferase (ALT) of 55), alkaline phosphatase (alk phos) of 127, and hyperbilirubinemia (total bilirubin of 2.4), with no known past medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of a 22-Year-Old Female with Lower Abdominal Pain and Abnormal Liver Tests

Immediate Clinical Assessment

This patient requires urgent evaluation for pregnancy-related liver disease, particularly HELLP syndrome or acute fatty liver of pregnancy (AFLP), given her age, sex, and presentation with abdominal pain and elevated bilirubin. 1

Critical First Steps

  • Obtain a pregnancy test immediately - this is the single most important initial test in any woman of reproductive age presenting with abdominal pain and liver abnormalities 1
  • Assess for preeclampsia features including blood pressure, proteinuria, and symptoms of headache, visual changes, or right upper quadrant pain 1
  • Order complete blood count with platelet count - thrombocytopenia (<150 × 10⁹/L) combined with elevated liver enzymes defines HELLP syndrome 1

Pattern Recognition

The laboratory pattern shows:

  • Mixed hepatocellular-cholestatic injury with AST/ALT ratio of 1.0 (both at 55 U/L) and alkaline phosphatase of 127 U/L 1, 2
  • Mild hyperbilirubinemia at 2.4 mg/dL suggests conjugated hyperbilirubinemia requiring further fractionation 3
  • R value calculation: (55/40)/(127/120) = 1.3, indicating a cholestatic pattern (R ≤2) 1

Pregnancy-Specific Considerations

If Pregnancy Test is Positive

HELLP syndrome must be excluded immediately as it affects 0.2-0.6% of pregnancies and can rapidly progress to maternal organ failure 1:

  • Platelets typically range from 50-150 × 10⁹/L 1
  • AST and ALT are usually 2-30 times upper limit of normal 1
  • Bilirubin is typically <5 mg/dL 1
  • Patients commonly present with abdominal pain and nausea/vomiting 1

Acute fatty liver of pregnancy (AFLP) is less common (0.005-0.010%) but more severe 1:

  • AST and ALT typically 300-1,000 U/L (higher than this patient) 1
  • Associated with hypoglycemia, elevated PT, low fibrinogen 1
  • Requires immediate delivery 1

Intrahepatic cholestasis of pregnancy (ICP) should be considered 1:

  • Presents with generalized pruritus, especially palms and soles 1
  • AST and ALT 2-30 times upper limit of normal 1
  • Total bile acids >10 μmol/L are diagnostic 1

If Pregnancy Test is Negative

Non-Pregnancy Differential Diagnosis

Immediate Workup Required

Obtain hepatitis serologies (hepatitis A IgM, hepatitis B surface antigen and core antibody, hepatitis C antibody) as viral hepatitis is a common cause of this presentation in young adults 3, 4

Perform right upper quadrant ultrasound to evaluate for:

  • Biliary obstruction (sensitivity 65-95% for hepatobiliary pathology) 3
  • Fatty liver disease 1
  • Hepatic masses or abscesses 1

Additional laboratory tests to order simultaneously 3, 4:

  • Direct and indirect bilirubin fractionation 3
  • Autoimmune markers (ANA, anti-smooth muscle antibody) - autoimmune hepatitis can present in young women 3, 5
  • Ceruloplasmin and serum copper - Wilson disease must be excluded in any patient under 40 with unexplained liver disease 6
  • Acetaminophen level and comprehensive drug/supplement history 4
  • Alcohol use assessment 1

Wilson Disease Screening Priority

In a 22-year-old with elevated liver enzymes, Wilson disease screening is mandatory 6:

  • Measure ceruloplasmin by oxidase method (more specific than nephelometry) 6
  • Serum copper levels >200 μg/dL suggest Wilson disease 6
  • AST:ALT ratio >2.2 in acute Wilson disease has 94% sensitivity 6
  • This patient's AST:ALT ratio of 1.0 makes acute Wilson disease less likely but does not exclude chronic Wilson disease 6

Clinical Decision-Making Algorithm

Hospitalization Criteria

This patient likely requires hospital admission based on 7:

  • Combination of abdominal pain, elevated liver enzymes, and hyperbilirubinemia 7
  • Need for serial liver function tests to monitor for progression 7
  • Elevated bilirubin (2.4 mg/dL) with transaminitis suggests more severe injury requiring close monitoring 7

Outpatient Management Acceptable If:

  • Pregnancy definitively excluded 1
  • Patient is clinically stable without signs of acute liver failure 4
  • No evidence of coagulopathy or encephalopathy 1
  • Reliable follow-up within 24-48 hours can be ensured 8
  • Serial laboratory monitoring can be arranged 7

Common Pitfalls to Avoid

Do not assume this is simple fatty liver disease - while NAFLD is common, the combination of symptoms, elevated bilirubin, and young age requires exclusion of more serious etiologies first 1, 4

Do not order "extensive testing" without clinical context - focused testing based on pre-test probability is more cost-effective and generates fewer false positives 8

Do not miss drug-induced liver injury - obtain detailed history of all medications, supplements, and herbal products, as this is a common and reversible cause 3, 4

Do not delay imaging - ultrasound should be performed urgently to exclude biliary obstruction, which requires different management 3, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Utility of analytical parameters in the diagnosis of liver disease].

Anales de medicina interna (Madrid, Spain : 1984), 2007

Guideline

Evaluation and Management of Conjugated Hyperbilirubinemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hospital Admission for Abdominal Pain and Elevated Liver Enzymes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the next steps in managing a patient with elevated liver enzymes, specifically an AST of 99?
What is the appropriate management for a patient with elevated globulin and liver enzymes?
What are the next steps for an 11-year-old male with elevated liver enzymes (aspartate aminotransferase (AST) and alanine aminotransferase (ALT)), hypercholesterolemia, and hypertriglyceridemia?
What is the cause of idiopathic elevated liver enzymes?
What is the appropriate workup and management for a patient with elevated liver enzymes?
What is the best course of treatment for a patient with a large rash on the lateral left chest wall and posterior upper left arm consistent with cellulitis, considering potential allergies and previous reactions to antibiotics, and possible history of Methicillin-resistant Staphylococcus aureus (MRSA) or other resistant organisms?
Should linagliptin (a dipeptidyl peptidase-4 (DPP-4) inhibitor) be started instead of gliclazide in a patient with type 2 diabetes and a history of severe hypoglycemic episodes or adrenal insufficiency?
Does a patient need to have an estimated Glomerular Filtration Rate (eGFR) of less than 60 ml/min/1.73m² to be diagnosed with Chronic Kidney Disease (CKD), or can a diagnosis be made with an eGFR of 60-89 ml/min/1.73m²?
What is the correlation between hypothyroid (underactive thyroid) disorder and insulin resistance, particularly in adults with a history of thyroid issues or metabolic syndrome?
What is the best approach to manage patient-ventilator asynchrony in a critically ill intensive care unit (ICU) patient with potential respiratory muscle weakness and pre-existing respiratory or cardiac conditions?
What is the recommended dosage of cefalexin (a cephalosporin antibiotic) for pediatric patients with varying weights and potential impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.